OFIX News and Press, Orthofix Medical Inc. From 09/14/22

Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced that President and Chief Executive Officer Jon Serbousek and Chief Financial Officer Doug Rice will be presenting during the upcoming Sidoti Virtual Investor Conferen...

The following slide deck was published by Orthofix Medical Inc. in conjunction with their 2022 Q2 earnings call. For further details see: Orthofix Medical Inc. 2022 Q2 - Results - Earnings Call Presentation

Orthofix Medical Inc. (OFIX) Q2 2022 Earnings Conference Call August 5, 2022 8:30 AM ET Company Participants Alexa Huerta – Senior Director-Investor Relations Jon Serbousek – President and Chief Executive Officer Doug Rice – Chief Financial O...

Orthofix press release ( NASDAQ: OFIX ): Q2 Non-GAAP EPS of $0.08 misses by $0.02 . Revenue of $118.1M (-2.7% Y/Y) misses by $0.15M . For further details see: Orthofix Non-GAAP EPS of $0.08 misses by $0.02, revenue of $118.1M misses by $0.15M

Net sales of $118.1 million, a decrease of 3% on a reported basis and flat on a constant currency basis over prior year Global Orthopedics net sales growth of 11% on a constant currency basis driven by new products and channel investments GAAP EPS of $0.12 ...

Orthofix Medical ( NASDAQ: OFIX ) is collaborating with CGBio to develop and commercialize Novosis bone growth materials and other future tissue regenerative solutions for the U.S. and Canadian markets. Under the license and distribution agreement, Orthofix will c...

Orthofix Medical Inc . (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced a strategic partnership agreement with CGBio, a developer of innovative, synthetic bone grafts currently used clinically in Asia for spine, orthopedic, trauma an...

Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced that it will release its second quarter 2022 financial results before market open on Friday, August 5, 2022. Jon Serbousek, President and Chief Executive Officer, and...

Orthofix Medical Inc . (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced the limited market release and first patient implant of the Virtuos ™ Lyograft, a first-of-its-kind, shelf-stable and complete autograft substitute fo...

Orthofix Medical Inc . (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, and LimaCorporate S.p.A., a global orthopedic company focused on digital innovation and patient-tailored hardware, today announced a licensing partnership for the U.S. market to...